Growth Metrics

Varex Imaging (VREX) Current Deferred Revenue (2016 - 2026)

Varex Imaging (VREX) has disclosed Current Deferred Revenue for 11 consecutive years, with $12.4 million as the latest value for Q1 2026.

  • On a quarterly basis, Current Deferred Revenue rose 31.91% to $12.4 million in Q1 2026 year-over-year; TTM through Jan 2026 was $12.4 million, a 31.91% increase, with the full-year FY2025 number at $13.0 million, up 64.56% from a year prior.
  • Current Deferred Revenue was $12.4 million for Q1 2026 at Varex Imaging, down from $13.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $14.6 million in Q3 2025 to a low of $7.4 million in Q3 2022.
  • A 5-year average of $10.1 million and a median of $9.8 million in 2024 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: fell 25.69% in 2024, then surged 80.25% in 2025.
  • Varex Imaging's Current Deferred Revenue stood at $9.2 million in 2022, then grew by 2.17% to $9.4 million in 2023, then decreased by 15.96% to $7.9 million in 2024, then soared by 64.56% to $13.0 million in 2025, then dropped by 4.62% to $12.4 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Current Deferred Revenue are $12.4 million (Q1 2026), $13.0 million (Q4 2025), and $14.6 million (Q3 2025).